Primary diagnosis of breast cancer occurred in 44% (N = 8) of patients; 50% of these primary tumors were estrogen receptor (ER) positive, 25% were progesterone receptor (PR) positive, 25% were human epidermal growth factor receptor 2 (HER2) positive and 25% were triple negative. Here, PGR is linked to breast carcinoma.